期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 56, 期 3, 页码 1074-1083出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm301519z
关键词
-
资金
- Georgia State University
- Georgia State University Research Program Enhancement Award in Bioinformatics
- National Institutes of Health [GM062920, GM053386]
- US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]
GRL-0519 (1) is a potent antiviral inhibitor of HIV-1 protease (PR) possessing tris-tetrahydrofuran (tris-THF) at P2. The high resolution X-ray crystal structures of inhibitor 1 in complexes with single substitution mutants PRR8Q, PRD30N, PR150V, PR154M, and PRV82A were analyzed in relation to kinetic data. The smaller valine side chain in PR150V eliminated hydrophobic interactions with inhibitor and the other subunit consistent with 60-fold worse inhibition. Asn30 in PRD30N showed altered interactions with neighboring residues and 18-fold worse inhibition. Mutations V82A and I54M showed compensating structural changes consistent with 6-7-fold lower inhibition. Gln8 in PRR8Q replaced the ionic interactions of wild type Arg8 with hydrogen bond interactions without changing the inhibition significantly. The carbonyl oxygen of Gly48 showed two alternative conformations in all structures likely due to the snug fit of the large tris-THF group in the S2 subsite in agreement with high antiviral efficacy of 1 on resistant virus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据